jili demo play
NEW YORK (AP) — Stocks fell broadly on Friday as Wall Street closed out a holiday-shortened week on a down note. The losses were made worse by sharp declines for the Big Tech stocks known as the “Magnificent 7”, which can heavily influence the direction of the market because of their large size. The S&P 500 fell 66.75 points, or 1.1%, to 5,970.84. Roughly 90% of stocks in the benchmark index lost ground, but it managed to hold onto a modest gain of 0.7% for the week. The Dow Jones Industrial Average fell 333.59 points, or 0.8%, to 42,992.21. The tech-heavy Nasdaq composite fell 298.33 points, or 1.5%, to 19,722.03. Semiconductor giant Nvidia slumped 2.1%. Microsoft declined 1.7%. Each has a market value above $3 trillion, giving the companies outsized sway on the S&P 500 and the Nasdaq. A wide range of retailers also fell. Amazon fell 1.5% and Best Buy slipped 1.5%. The sector is being closely watched for clues on how it performed during the holiday shopping season. Energy stocks held up better than the rest of the market, with a loss of less than 0.1% as crude oil prices rose. “There’s just some uncertainty over this relief rally we’ve witnessed since last week,” said Adam Turnquist, chief technical strategist for LPL Financial. The S&P 500 gained nearly 3% over a 3-day stretch before breaking for the Christmas holiday. On Thursday, the index posted a small decline. Despite Friday's drop, the market is moving closer to another standout annual finish . The S&P 500 is on track for a gain of around 25% in 2024. That would mark a second consecutive yearly gain of more than 20%, the first time that has happened since 1997-1998. The gains have been driven partly by upbeat economic data showing that consumers continued spending and the labor market remained strong. Inflation, while still high, has also been steadily easing. A report on Friday showed that sales and inventory estimates for the wholesales trade industry fell 0.2% in November, following a slight gain in October. That weaker-than-expected report follows an update on the labor market Thursday that showed unemployment benefits held steady last week. The stream of upbeat economic data and easing inflation helped prompt a reversal in the Federal Reserve's interest rate policy this year. Expectations for interest rate cuts also helped drive market gains. The central bank recently delivered its third cut to interest rates in 2024. Even though inflation has come closer to the central bank's target of 2%, it remains stubbornly above that mark and worries about it heating up again have tempered the forecast for more interest rate cuts. Inflation concerns have added to uncertainties heading into 2025, which include the labor market’s path ahead and shifting economic policies under incoming President Donald Trump. Worries have risen that Trump’s preference for tariffs and other policies could lead to higher inflation , a bigger U.S. government debt and difficulties for global trade. Amedisys rose 4.7% after the home health care and hospice services provider agreed to extend the deadline for its sale to UnitedHealth Group. The Justice Department had sued to block the $3.3 billion deal, citing concerns the combination would hinder access to home health and hospice services in the U.S. The move to extend the deadline comes ahead of an expected shift in regulatory policy under Trump. The incoming administration is expected to have a more permissive approach to dealmaking and is less likely to raise antitrust concerns. In Asia, Japan’s benchmark index surged as the yen remained weak against the dollar. Stocks in South Korea fell after the main opposition party voted to impeach the country’s acting leader. Markets in Europe gained ground. Bond yields held relatively steady. The yield on the 10-year Treasury rose to 4.62% from 4.59% late Thursday. The yield on the two-year Treasury remained at 4.33% from late Thursday. Wall Street will have more economic updates to look forward to next week, including reports on pending home sales and home prices. There will also be reports on U.S. construction spending and snapshots of manufacturing activity.
From the DBS leadership renewal to the Straits Times Index surging to a 17-year high, these are some events this year that captured headlines. G insurer Allianz announced on Dec 16 that it is scrapping its 1.5 billion euro (S$2.1 billion) offer to buy at least 51 per cent of the shares in Income Insurance. Its offer had ignited public criticism as many voiced concerns on it detracting from Income’s social mission to provide affordable insurance to low-income workers. In October, the Singapore government also rejected the deal after assessing that it was not in the public’s interest for the proposed transaction to proceed in its initial form. However, it said it was open to the deal proceeding with new arrangements so long as the concerns raised were addressed. Singapore’s largest lender will soon welcome its first female chief executive officer. Tan Su Shan, who is currently head of institutional banking at DBS, will replace Piyush Gupta next year . In August, Tan was named deputy chief executive ahead of her upcoming replacement of Gupta, who will retire at the bank’s next annual general meeting on Mar 28, 2025. The board said that the decision to appoint the 56-year-old – who has more than 35 years of experience in consumer banking, wealth management and institutional banking under her belt – was “unanimous”. Lawrence Wong was sworn in as prime minister on May 15 , succeeding former prime minister Lee Hsien Loong. Wong, who entered Parliament in 2011 before being appointed as the minister of state for defence and education shortly after, has been in politics for 13 years. He was selected by peers in 2022 to be the leader of Singapore’s fourth-generation team after then deputy prime minster Heng Swee Keat announced in April 2021 that he was stepping down as presumptive PM-in-waiting due to his age, challenges of the pandemic and the heavy demands of the job. Kitefoiler Maximilian Maeder’s Olympic bronze was the city-state’s sole medal at this year’s Paris Games. His Olympic win has earned him a coveted place among the ranks of Singapore’s Olympians – making him the sixth one in the nation’s sporting history. Just shy of 18 years at the time of his crowning achievement, Maeder is also the nation’s youngest Olympic medallist to date. Private cord-blood bank Cordlife’s troubles over the mishandling of cord-blood units deepened in 2024. Four directors and former group CEO Tan Poh Lan were arrested by the Commercial Affairs Department in March. The Ministry of Health (MOH) had imposed a six-month suspension on the cord-blood bank in November 2023 that prohibited it from collecting, testing, processing and/or storing any new cord blood and human tissues after investigations revealed that it had inappropriately stored cord blood above acceptable temperature limits. MOH has since granted the cord-blood bank permission to resume cord-blood banking services “in a controlled manner” as of September. Former transport minister S Iswaran was sentenced to 12 months in jail on Oct 3 after he pleaded guilty to five charges in September. The sentencing sets a precedent for a provision that has not been used in Singapore since independence: Section 165 of the Penal Code, which prohibits a public servant from accepting or obtaining anything of value for free or inadequate payment, from any person with whom they are involved in an official capacity. Beleaguered billionaire Lim Oon Kuin was sentenced to 17 years and six months in prison on three charges of cheating and forgery after a 62-day trial that prosecutors said was one of Singapore’s most serious cases of trade financing fraud. The owner of the oil trading company Hin Leong, who initially faced 130 criminal charges of forgery and cheating involving a total sum of US$2.7 billion, said he would appeal his conviction. The benchmark Straits Times Index (STI) surged to a 17-year high on Nov 8 , climbing up 1.4 per cent or 50.88 points to 3,724.37. This came as the trio of local banking stocks rallied and soared to fresh records. Analysts have listed factors such as expectations that the US Federal Reserve might slow down the pace of interest rate cuts after the US presidential elections in particular. That is positive for the banks, which are STI heavyweights. A series of job cuts occurred this year. Here are a few: Carousell axed 76 jobs or 7 per cent of its total headcount across regional offices on Dec 6, citing the need to reallocate resources away from certain business areas to others that showed promise. Affected employees were given layoff packages including one month of salary for every year of service, with a minimum of three months’ salary. Healthtech startup Dr Anywhere in December announced it laid off around 45 or 8.1 per cent of its workforce in South-east Asia and Singapore. In 2023, Dr Anywhere posted a US$23.6 million operating loss on a US$62.1 million revenue. Beverage manufacturer Yeo Hiap Seng laid off 25 employees after Oatly’s closure of its Singapore manufacturing operations. That is in addition to the 34 Oatly workers affected by the closure, bringing the total to 59. The company said the affected workers had been hired specifically to support Oatly’s production at Yeo’s Senoko plant, and were retrenched as a direct result of Oatly ceasing its manufacturing in Singapore. Sea is cutting more jobs at e-commerce unit Shopee in Indonesia , Bloomberg reported in November, citing sources. Singapore Post (SingPost) sacked three of its senior management staff as they were found to be negligent in the handling of internal investigations over a whistle-blower report that it received earlier this year. The employment of group chief executive Vincent Phang, group chief financial officer Vincent Yik, and the chief executive of the company’s international business unit Li Yu were terminated with immediate effect on Dec 21, 2024.
U.S. president-elect Donald Trump says he told Canadian hockey legend Wayne Gretzky during a Christmas Day visit that he should run for prime minister of Canada. “I just left Wayne Gretzky, ‘The Great One’ as he is known in ice-hockey circles,” Trump posted on his Truth Social platform Wednesday afternoon. “I said, ‘Wayne, why don’t you run for prime minister of Canada, soon to be known as the governor of Canada — you would win easily, you wouldn’t even have to campaign.’ He had no interest,” Trump wrote. His comment about being governor of Canada refers to Trump repeatedly suggesting the country become a U.S. state, which Ottawa insists is a joke. Trump added that it would be “fun to watch” if Canadians launched a movement to get the retired hockey player to seek office. The Canadian Press has tried to contact Gretzky through his agents. Experts have said that Ottawa is rightfully focused on the prospect of damaging tariffs under the looming Trump presidency instead of pushing back on rhetoric about annexing or purchasing Canada. Prime Minister Justin Trudeau leads a minority government that could be toppled by a confidence vote next year, following the surprise resignation of finance minister Chrystia Freeland. Trump also expressed Christmas greetings to Trudeau, again referring to him as a governor and claiming that Canadians would see a tax cut of more than 60 per cent if the country became an American state. “Their businesses would immediately double in size, and they would be militarily protected like no other country anywhere in the world,” Trump wrote in a post that also alluded to his desire to annex Greenland and the Panama Canal. Gretzky has previously backed Conservative politicians, such as former Ontario Progressive Conservative leader Patrick Brown during his run for the party leadership. During the 2015 federal election, Conservative leader Stephen Harper interviewed Gretzky in front of hundreds of supporters as the Tories unsuccessfully sought re-election. At the event, Gretzky told Harper he thought he had been an “unreal prime minister” who had been “wonderful to the whole country.” Gretzky later said he always follows a prime minister’s request, regardless of political stripe, noting he had once hosted a lunch for former Liberal prime minister Pierre Trudeau.There are times when a postseason bowl seems like the first game of next year for the participating teams. That cliche means something a little different for NC State and East Carolina. The Wolfpack and Pirates face each other in the Military Bowl on Saturday in Annapolis, Maryland. Then they'll see each other again in about eight months. NC State opens the 2025 season at home against ECU on Aug. 30. There is certainly plenty of familiarity between these two programs, even though NC State (6-6) is in the ACC and East Carolina (7-5) is in the AAC. The teams — located about 80 miles apart — have met 32 times, most recently in 2022 when the Wolfpack won 21-20. From 1970-87, these teams played each other every year. Since 2004, they haven't gone more than two consecutive seasons without meeting. “Hour and a half down the road and you're playing — whether you play every year or don't play every year — I think it's still a rivalry," East Carolina coach Blake Harrell said. "Our fans still get excited. They still think that's a rivalry. Our players still think that's a rivalry.” NC State leads the series 19-13 and has won three straight — but East Carolina won three in a row before that. “It's weird playing a team that we open with next year,” Wolfpack coach Dave Doeren said. “We don't play them that much. We play them every three years, so it's really a roster turnover. Every time we see them, it's a different ballclub for the most part. But yeah, finishing with who you open with is unique.” NC State and East Carolina met in the Peach Bowl in 1992 — during an eight-year hiatus in their regular-season series. ECU scored three touchdowns in the final 7:26 to win 37-34. “We had that time during COVID, we obviously all had some down time. I remember searching through YouTube, just past games to check out. That game did pop up," Harrell said. "That was a special moment for that team and that program at the time, and this could be a special moment for this team and this program.” NC State is playing in the Military Bowl for the first time. East Carolina was supposed to participate in 2021, but the game was canceled. The Pirates lost to Maryland in the 2010 edition. Harrell took over on an interim basis in the middle of the season when Mike Houston was fired. After leading the Pirates to four straight wins, Harrell had the interim tag removed . Freshman CJ Bailey took over at quarterback for NC State this season after concussion problems ended Grayson McCall's career. Bailey has completed 64.1% of his passes. Only Philip Rivers and Russell Wilson threw for more touchdowns as a freshman for the Wolfpack than Bailey, who has 14 TD tosses. “He's a really good player. Doesn't play like a freshman to me,” Harrell said. "Makes really good throws down the field, has a really good arm, and then if he takes off scrambling or if the quarterback-designed run game, he's a long strider. He can eat up some ground. Nobody ever catches him." Get poll alerts and updates on the AP Top 25 throughout the season. Sign up here . AP college football: https://apnews.com/hub/ap-top-25-college-football-poll and https://apnews.com/hub/college-footballAn online debate over foreign workers in tech shows tensions in Trump’s political coalition
Image Credit: Kyverna Therapeutics (PRNewsfoto/Kyverna Therapeutics) Key Leadership Appointments Bring New Skills and Capabilities to Organization EMERYVILLE, Calif. , Dec. 13, 2024 /PRNewswire/ -- Kyverna Therapeutics, Inc. (Kyverna), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, announced the recent appointments of Dan Maziasz as Chief Business Officer, Cara Bauer as Chief Human Resources Officer, and Tracy Rossin as Senior Vice President of Corporate Affairs, Communications and Investor Relations. "I'm pleased to welcome three industry leaders to our Kyverna team," said Warner Biddle , Chief Executive Officer of Kyverna. "Dan, Cara and Tracy bring important new skills and capabilities to Kyverna as we continue to support the company's next phase of growth and work to bring a transformative change to patients living with severe autoimmune diseases." Mr. Maziasz brings over 25 years of leadership and business experience across several leading biotechnology and large pharmaceutical companies. Mr. Maziasz most recently served as Chief Business Officer at Atara Biotherapeutics, the first company in the world to receive regulatory approval of an allogeneic T-cell immunotherapy. At Atara, Mr. Maziasz led various corporate initiatives including strategic planning, licensing transactions with industry partners, and research collaborations with academic groups. Before his time at Atara, Mr. Maziasz was Vice President, Corporate Strategy and Business Development at Kite Pharma, a global cell therapy leader, prior to its acquisition by Gilead Sciences. Mr. Maziasz also spent more than a decade at Amgen, where he held roles of increasing responsibility in the US, Europe , and Asia across business development, corporate strategy, finance, and commercial functions. Ms. Bauer brings more than 25 years of experience in global human resources leadership to Kyverna, having served most recently as Global Head of Human Resources at Kite, a Gilead Company, where she oversaw all HR strategy and operations during a period of hypergrowth and global expansion which strengthened the company's leadership position in cell therapy. Prior to this role, she served as the Global Head of HR for the Entertainment Division at Riot Games where she worked directly with the founders to build an Entertainment Studio separate from the core gaming business. Ms. Bauer has also held various HR leadership roles at companies such as Netflix, Amgen, Gartner and Novo Nordisk. Ms. Rossin brings more than 20 years of strategic communications experience to Kyverna, having most recently served as the Head of Public Affairs at Kite, where she was responsible for leading corporate, product and employee communications in addition to patient advocacy. Prior to this role, she served as Vice President, Global Head of Communications at Innate Pharma, an oncology-focused biotech company, where she led both corporate and financial communications. Ms. Rossin also spent more than 12 years at AstraZeneca/MedImmune, where she held multiple U.S. and global communications roles for key therapeutic areas across AstraZeneca's portfolio before serving as the Head of Corporate Affairs at MedImmune, the global biologics research and development arm of AstraZeneca. Before joining AstraZeneca, she held various positions at global public relations agencies working with corporate and healthcare related clients. Inducement Grant In connection with the appointment of Mr. Maziasz as Kyverna's Chief Business Officer, on December 9, 2024 , Kyverna granted Mr. Maziasz an option to purchase 350,000 shares of its common stock (Option). The Option was granted pursuant to the Kyverna Therapeutics, Inc. 2024 Inducement Equity Incentive Plan, as approved by the Compensation Committee of Kyverna's Board of Directors on September 14, 2024 , and was granted as an inducement material to Mr. Maziasz's employment with Kyverna in accordance with Nasdaq Listing Rule 5635(c)(4). The exercise price of the Option was $4.86 , the closing price of Kyverna's common stock on December 9, 2024 , the date of grant. The Option will vest over four years, with 25% of the total number of shares subject to the Option vesting on the one-year anniversary of Mr. Maziasz's appointment and 1/48th of the total number of shares subject to the Option vesting monthly thereafter, subject in each case to Mr. Maziasz's continued service to Kyverna on each vesting date. Kyverna is providing this information in accordance with Nasdaq Listing Rule 5635(c)(4). About Kyverna Therapeutics Kyverna Therapeutics, Inc. (Nasdaq: KYTX) is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. Our lead CAR T-cell therapy candidate, KYV-101 is advancing through clinical development with sponsored clinical trials across two broad areas of autoimmune disease: rheumatology and neurology, including Phase 2 trials for stiff-person syndrome, multiple sclerosis and myasthenia gravis, a Phase 1/2 trial for systemic sclerosis, and two ongoing multi-center Phase 1/2 trials in the United States and Germany for patients with lupus nephritis. Kyverna's pipeline includes next-generation CAR T-cell therapies in both autologous and allogeneic formats with properties intended to be well suited for use in B cell-driven autoimmune diseases. For more information, please visit https://kyvernatx.com . Forward-Looking Statements Statements in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements." The words, without limitation, "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these or similar identifying words. Forward-looking statements in this press release include, without limitation, those related to: the potential impact of the clinical outcomes from the ongoing clinical programs; the potential impact of the new data on the treatment efficacy and safety profile of KYV-101; the potential that the results of the ongoing trials could drastically change the treatment landscape for the targeted autoimmune diseases; Kyverna's goals to develop certain paradigm-shifting treatment options; the potential for KYV-101 to provide durable, immunosuppressant-free remission for autoimmune disease patients; Kyverna's beliefs about the differentiated properties of KYV-101; and Kyverna's clinical trials, investigator-initiated trials and named-patient activities. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including: uncertainties related to market conditions, and other factors discussed in the "Risk Factors" section of Kyverna's most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q that Kyverna has filed or may subsequently file with the U.S. Securities and Exchange Commission. Any forward-looking statements contained in this press release are based on the current expectations of Kyverna's management team and speak only as of the date hereof, and Kyverna specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise. Contact: Investors: InvestorRelations@kyvernatx.com Media: media@kyvernatx.com View original content to download multimedia: https://www.prnewswire.com/news-releases/kyverna-therapeutics-strengthens-leadership-team-to-accelerate-next-phase-of-growth-302331659.html SOURCE Kyverna Therapeutics
With two-way star Travis Hunter of Colorado and Boise State running back Ashton Jeanty leading the field, these certainly aren't your typical Heisman Trophy contenders. Sure, veteran quarterbacks Dillon Gabriel from top-ranked Oregon and Cam Ward of No. 15 Miami are finalists for college football's most prestigious award as well, but the 90th annual ceremony coming up Saturday night at Lincoln Center in New York City offers a fresh flavor this year. To start with, none of the four are from the powerhouse Southeastern Conference, which has produced four of the past five Heisman winners — two each from Alabama and LSU. Jeanty, who played his home games for a Group of Five team on that peculiar blue turf in Idaho more than 2,100 miles from Manhattan, is the first running back even invited to the Heisman party since 2017. After leading the country with 2,497 yards rushing and 29 touchdowns, he joined quarterback Kellen Moore (2010) as the only Boise State players to be named a finalist. "The running back position has been overlooked for a while now," said Jeanty, who plans to enter the 2025 NFL draft. "There's been a lot of great running backs before me that should have been here in New York, so to kind of carry on the legacy of the running back position I think is great. ... I feel as if I'm representing the whole position." With the votes already in, all four finalists spent Friday conducting interviews and sightseeing in the Big Apple. They were given custom, commemorative watches to mark their achievement. "I'm not a watch guy, but I like it," said Hunter, flashing a smile. The players also took photos beneath the massive billboards in Times Square and later posed with the famous Heisman Trophy, handed out since 1935 to the nation's most outstanding performer. Hunter, the heavy favorite, made sure not to touch it yet. A dominant player on both offense and defense who rarely comes off the field, the wide receiver/cornerback is a throwback to generations gone by and the first full-time, true two-way star in decades. On offense, he had 92 catches for 1,152 yards and 14 touchdowns this season to help the 20th-ranked Buffaloes (9-3) earn their first bowl bid in four years. On defense, he made four interceptions, broke up 11 passes and forced a critical fumble that secured an overtime victory against Baylor. Hunter played 688 defensive snaps and 672 more on offense — the only Power Four conference player with 30-plus snaps on both sides of the ball, according to Colorado research. Call him college football's answer to baseball unicorn Shohei Ohtani. "I think I laid the ground for more people to come in and go two ways," Hunter said. "It starts with your mindset. If you believe you can do it, then you'll be able to do it. And also, I do a lot of treatment. I keep up with my body. I get a lot of recovery." Hunter is Colorado's first Heisman finalist in 30 years. The junior from Suwanee, Georgia, followed flashy coach Deion Sanders from Jackson State, an HBCU that plays in the lower level FCS, to the Rocky Mountains and has already racked up a staggering combination of accolades this week, including The Associated Press player of the year. Hunter also won the Walter Camp Award as national player of the year, along with the Chuck Bednarik Award as the top defensive player and the Biletnikoff Award for best wide receiver. "It just goes to show that I did what I had to do," Hunter said. Next, he'd like to polish off his impressive hardware collection by becoming the second Heisman Trophy recipient in Buffaloes history, after late running back Rashaan Salaam in 1994. "I worked so hard for this moment, so securing the Heisman definitely would set my legacy in college football," Hunter said. "Being here now is like a dream come true." Jeanty carried No. 8 Boise State (12-1) to a Mountain West Conference championship that landed the Broncos the third seed in this year's College Football Playoff. They have a first-round bye before facing the SMU-Penn State winner in the Fiesta Bowl quarterfinal on New Year's Eve. The 5-foot-9, 215-pound junior from Jacksonville, Florida, won the Maxwell Award as college football's top player and the Doak Walker Award for best running back. Jeanty has five touchdown runs of at least 70 yards and has rushed for the fourth-most yards in a season in FBS history — topping the total of 115 teams this year. He needs 132 yards to break the FBS record set by Heisman Trophy winner Barry Sanders at Oklahoma State in 1988. In a pass-happy era, however, Jeanty is trying to become the first running back to win the Heisman Trophy since Derrick Henry for Alabama nine years ago. In fact, quarterbacks have snagged the prize all but four times this century. Gabriel, an Oklahoma transfer, led Oregon (13-0) to a Big Ten title in its first season in the league and the No. 1 seed in the College Football Playoff. The steady senior from Hawaii passed for 3,558 yards and 28 touchdowns with six interceptions. His 73.2% completion rate ranks second in the nation, and he's attempting to join quarterback Marcus Mariota (2014) as Ducks players to win the Heisman Trophy. "I think all the memories start to roll back in your mind," Gabriel said. Ward threw for 4,123 yards and led the nation with a school-record 36 touchdown passes for the high-scoring Hurricanes (10-2) after transferring from Washington State. The senior from West Columbia, Texas, won the Davey O'Brien National Quarterback of the Year award and is looking to join QBs Vinny Testaverde (1986) and Gino Torretta (1992) as Miami players to go home with the Heisman. "I just think there's a recklessness that you have to play with at the quarterback position," Ward said.
Will Jamaal Williams Play in Week 13? NFL Injury Status, News & UpdatesBriaCell Therapeutics Announces Closing of $5.5 Million Public Offering
CLEMSON, S.C. (AP) — South Carolina coach Shane Beamer has no doubt about where his surging, 16th-ranked Gamecocks belong in the postseason — chasing a national championship. “It's hard for me to say we're not one of the 12 best teams in the country,” a giddy Beamer said Saturday after watching his team pull off another late miracle, courtesy of quarterback LaNorris Sellers, to defeat No. 12 Clemson 17-14. Sellers scored his second touchdown , this one from 20 yards out with 1:08 to play, for South Carolina's sixth straight victory, four of them in that run coming over ranked opponents. Are you paying attention, College Football Playoff selectors? “If the committee's job is to pick the 12 best teams, you tell me,” Beamer said. It would be hard to pick against the Gamecocks (9-3, 5-3 SEC; No. 15 CFP) with Sellers, a confident, poised freshman, playing as well as he is. He finished with 166 yards rushing and 164 yards passing. Two games ago, he set career bests with 353 yards passing and five TD throws in twice rallying the Gamecocks from fourth-quarter deficits to defeat Missouri 34-30. This time, Sellers shrugged off his interception near Clemson's goal with less than 11 minutes left to lead his team to a field goal and then his game winner. Sellers spun away from defender Peter Woods in the backfield, broke through the line and cut left to reach the end zone. Sellers hears defenders get angry when they get their hands on but can't bring down the speedy, 6-foot-3 passer in his first year since taking over for Spencer Rattler. How does he do it? “I don't really know,” Sellers said. Beamer had an answer to that one, too. “He's a competitor, he's a warrior,” Beamer said. “He doesn't get too high or too low. He's out there having fun.” The Gamecocks hope to have more fun in a week so, confident they'll hear their name called among the expanded field of 12 that will play for a national crown. They know, too, they'll have Sellers leading the way. “He's a magician, man,” Gamecocks linebacker Demetrius Knight Jr. said. “LeMagic, LeComeback, whatever you want to call him.” Clemson (9-3, 7-1 ACC, No. 12) had a final chance and drove to the South Carolina 18 with 16 seconds left — well within reach of a tying field goal — when Cade Klubnik was intercepted by Knight to end things. The Gamecocks were 3-3 after losing at Alabama in mid-October and then pulled off their longest winning streak since 2012. The Tigers also were hoping to play their way into the CFP's 12-team field. But their offense had too many costly mistakes and their defense could not corral Sellers. “He's a great player and made great players,” Clemson linebacker Barrett Carter said. Still, there could be postseason hope for Clemson, which will cross its fingers and pray Syracuse can pull off an upset over No. 8 Miami later Saturday that would get the Tigers into the Atlantic Coast Conference title game next week against SMU. Both teams came in on highs, the Tigers having won three straight and the Gamecocks five in a row, including three consecutive over ranked opponents Texas A&M, Vanderbilt and Missouri. But neither team found its offensive rhythm in the opening half. Sellers was sacked by T.J. Parker and turned the ball over as Parker recovered with South Carolina inside the Clemson 20. The Tigers drove to the South Carolina 11 and turned down a chip-shot field goal to go for it on fourth-and-1. But Mafah was stopped way short by Jalon Kilgore and Knight. Klubnik had scoring runs of 13 and 18 yards for the Tigers. South Carolina: What a run by the Gamecocks, who before the season were picked 13th in the SEC and now may find themselves part of the national championship playoff field. Clemson: The Tigers lost to both ranked SEC opponents they faced this season, first to No. 1 Georgia to start the year and then to rival South Carolina. Tigers coach Dabo Swinney was proud of his team's regular season but knew the loss might leave it short of getting back to the playoff. “We could've had a great year,” he said. "We got better this season, a lot of positives to build on. “But this one is tough. It's tough. It hurts,” he continued. Shane Beamer knew what a big week it was when he got a voicemail from his old boss, former South Carolina coach Steve Spurrier. “Beamer, you're doing great,” said Spurrier, who coached the Gamecocks from 2005-2014. “This might be the biggest game in the history of South Carolina.” South Carolina and Clemson both await their postseason games. Get poll alerts and updates on the AP Top 25 throughout the season. Sign up here . AP college football: https://apnews.com/hub/ap-top-25-college-football-poll and https://apnews.com/hub/college-footballThamel: Bill Belichick, North Carolina and college football's new worldKSE-100 recovers 928 points amid strong earnings outlook A Pakistani stock-broker monitors shares prices at teh Pakistan Stock Exchange on January 16, 2023. —INP KARACHI: Stocks witnessed some recovery on Friday, and the benchmark KSE-100 index closed 928 points higher amid a strong earnings outlook. googletag.cmd.push(function() { googletag.display('div-gpt-ad-1700472799616-0'); }); The Pakistan Stock Exchange’s (PSX) benchmark KSE-100 index increased by 927.86 points or 0.84 per cent to 111,351.18 points against 110,423.32 points recorded in the last session. The highest index of the day remained at 112,043.77 points, while the lowest level was recorded at 110,246.93 points. Ahsan Mehanti, an analyst at Arif Habib Corp, said, “Stocks showed recovery near year-end close on strong earnings outlook.” He said the strong rupee, reports of surging exports, higher global crude oil prices and falling government bond yields amid thin inflation played a catalyst role in the bullish close at the PSX. The KSE-30 index increased by 261.01 points or 0.75 per cent to 35,039.05 points against 34,778.04 points. Traded shares increased by 187 million shares to 815.92 million shares from 628.026 million shares. The trading value dropped to Rs32.917 billion from Rs33.582 billion. Market capital expanded to Rs14.126 trillion against Rs14.014 trillion. Of the 443 companies active in the session, 223 closed in green, 176 in red and 44 remained unchanged. Analyst Nabeel Haroon at Topline Securities said that recovery was observed as the KSE 100 index largely traded in the positive zone to close at the 111,351 level (up by 0.84 per cent). Traded value-wise TRG (Rs2.92 billion), MARI (Rs2 billion), PSO (Rs1.77 billion), OGDC (Rs1.28 billion) and MEBL (Rs835 million) dominated the trading activity. Top contribution to the index came from MARI, MEBL, PSO, BAFL and TRG, as they cumulatively contributed 416 points to the index. TRG again remained in the limelight, as disclosure with respect to Greentree Holdings (substantial shareholder) intention to buy up to 35.145 per cent stake in TRG Pakistan (TRG) garnered investor interest. The highest increase was recorded in Hoechst Pakistan Limited, which rose by Rs147.06 to Rs2,847.06 per share, followed by Ismail Industries Limited, which increased by Rs79.71 to Rs1,964.71 per share. A significant decline was noted in Rafhan Maize Products Company Limited, which fell by Rs113.46 to Rs8,888.44 per share; Nestle Pakistan Limited followed it, which closed lower by Rs53.11 to Rs7,377.70 per share. Brokerage Arif Habib Ltd stated the KSE-100 Index staged a recovery on Friday, closing the week with a gain of 1.4 per cent week-on-week (WoW) after facing pressure from a two-day sell-off earlier in the week. In a key development, the National Bank of Pakistan (NBP, +1.43 per cent) announced that the US Federal Reserve has terminated its enforcement action against the bank, improving investor sentiment. Despite the positive close, analysts noted that the KSE-100 remains range-bound and continues to lack clear directional momentum. Investors are expected to monitor upcoming economic indicators and global market cues for further guidance. Fauji Foods Ltd remained the volume leader with 104.428 million shares, which closed higher by 69 to Rs17.08 per share. WorldCall Telecom, with 74.132 million shares, followed it, which closed lower by one paisa to Rs1.71 per share. Other significant turnover stocks included Cnergyico PK, TRG Pak Ltd, Hascol Petrol, Ghani Chemical, Sui South Gas, Silk Bank Ltd, K-Electric Ltd, and Ghani Glo Hol. In the futures market, 303 companies recorded trading, 170 of which increased, 132 decreased, and one remained unchanged.
Jayhawks rally in 2nd half, beat Tigers to take Island Division title
Stock market today: Wall Street slips as the 'Magnificent 7' weighs down the market
- Previous: jili 58
- Next: jili welcome bonus
